Skip to main content
Top
Published in: Reactions Weekly 1/2021

01-03-2021 | Cough | Case report

Nonacog-alfa

Various toxicities: 5 case reports

Published in: Reactions Weekly | Issue 1/2021

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Liesner R, et al. Safety and efficacy of nonacog alfa for the treatment of haemophilia B in children younger than 6 years of age in a routine clinical care setting: the EUREKIX registry study. Haemophilia 27: e60-e68, No. 1, Jan 2021. Available from: URL: http://doi.org/10.1111/hae.14215 Liesner R, et al. Safety and efficacy of nonacog alfa for the treatment of haemophilia B in children younger than 6 years of age in a routine clinical care setting: the EUREKIX registry study. Haemophilia 27: e60-e68, No. 1, Jan 2021. Available from: URL: http://​doi.​org/​10.​1111/​hae.​14215
Metadata
Title
Nonacog-alfa
Various toxicities: 5 case reports
Publication date
01-03-2021
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-92492-2

Other articles of this Issue 1/2021

Reactions Weekly 1/2021 Go to the issue

Case report

Durvalumab

Case report

Adalimumab